Director Ann Miller to resign from Puma Biotechnology board effective Dec 31, 2021

PUMA BIOTECHNOLOGY, INC.

Ann Miller notified her resignation as director on December 9, 2021, effective December 31, 2021.
Resignation is not the result of any disagreement with the company according to the filing.
No replacement director has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ann Miller

director

PBYI · PUMA BIOTECHNOLOGY, INC.

Effective: 2021-12-31
Filed: December 14, 2021, 6:59 PM ET

On December 9, 2021, Ann Miller notified Puma Biotechnology, Inc. ("Puma" or the "Company") of her decision to resign as a director of the Company, effective December 31, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Ann Miller resigned as director at PUMA BIOTECHNOLOGY, INC..

Action: resigned
Role: director

Exact text from the filing

On December 9, 2021, Ann Miller notified Puma Biotechnology, Inc. ("Puma" or the "Company") of her decision to resign as a director of the Company, effective December 31, 2021.

View on SEC.gov

PUMA BIOTECHNOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001437749-21-028442

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.